LEXICON PHARMACEUTICALS, INC. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
The Woodlands, TX
SEC filing record 1 source field available
Fiscal year end
31 December
LEXICON PHARMACEUTICALS, INC. has filed 1,396 SEC EDGAR filings since 09 Feb 2000

SEC filing history

Showing 551-575 of 994 matching filings.

Per page
25
Current page
23
4

PRIMARY DOCUMENT

Filing date
27 Apr 2018
Reporting date
27 Apr 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
27 Apr 2018
Reporting date
27 Apr 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
27 Apr 2018
Reporting date
27 Apr 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
27 Apr 2018
Reporting date
27 Apr 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-30111

8-K - ANNUAL MEETING (4-26-2018)

Filing date
26 Apr 2018
Reporting date
26 Apr 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-30111

FORM 8-K (4-23-18)

Filing date
23 Apr 2018
Reporting date
23 Apr 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 000-30111

2018 PROXY NOTICE

Filing date
16 Mar 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 000-30111

2018 DEFINITIVE PROXY

Filing date
16 Mar 2018
Reporting date
16 Mar 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
02 Mar 2018
Reporting date
28 Feb 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
02 Mar 2018
Reporting date
28 Feb 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
02 Mar 2018
Reporting date
28 Feb 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
02 Mar 2018
Reporting date
28 Feb 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
02 Mar 2018
Reporting date
28 Feb 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
02 Mar 2018
Reporting date
28 Feb 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
02 Mar 2018
Reporting date
28 Feb 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-30111

FORM 8-K EARNINGS RELEASE (02-22-18)

Filing date
22 Feb 2018
Reporting date
22 Feb 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-60409

SC 13G/A filing

Filing date
13 Feb 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-60409

SC 13G/A filing

Filing date
13 Feb 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
12 Feb 2018
Reporting date
08 Feb 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
12 Feb 2018
Reporting date
08 Feb 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
12 Feb 2018
Reporting date
08 Feb 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
12 Feb 2018
Reporting date
08 Feb 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
12 Feb 2018
Reporting date
08 Feb 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
12 Feb 2018
Reporting date
08 Feb 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .